Skip to main content
CORESTEMCHEMON Inc. logo

CORESTEMCHEMON Inc. — Investor Relations & Filings

Ticker · 166480 ISIN · KR7166480004 KO Professional, scientific and technical activities
Open in API
Filings indexed 274 across all filing types
Latest filing 2021-02-25 Legal Proceedings Report
Country KR South Korea
Listing KO 166480

About CORESTEMCHEMON Inc.

https://www.corestemchemon.com/eng/main…

CORESTEMCHEMON Inc. is a biotechnology company operating through two main divisions: a biopharmaceutical unit and a non-clinical Contract Research Organization (CRO) unit. The biopharmaceutical division is dedicated to the research and development of new drugs based on stem cell therapy technology. Its clinical pipeline primarily targets neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), cerebellar ataxia, and multiple sclerosis, as well as autoimmune diseases like systemic lupus erythematosus (SLE) and fibrosis. The non-clinical CRO division provides comprehensive preclinical services, conducting essential toxicity and efficacy evaluations for pharmaceuticals, biopharmaceuticals, cosmetics, and medical devices to support regulatory approval processes.

Recent filings

Filing Released Lang Actions
파생상품거래손실발생
Legal Proceedings Report Classification · 1% confidence The document is a regulatory disclosure regarding a derivative transaction loss (파생상품거래손실발생) filed by the company Corestem. It details the financial impact of derivative valuation losses related to convertible bonds. Since this is a specific regulatory disclosure of a material financial event that does not fit into categories like earnings releases or annual reports, it is classified as a general regulatory filing.
2021-02-25 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company Corestem. It outlines the date, location, and agenda items (such as financial statement approval, director re-election, and compensation limits) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation or notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2021-02-25 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company Corestem. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits) for the upcoming meeting. This type of document is a standard proxy solicitation or notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2021-02-25 Korean
기타시장안내(연구개발 우수기업 매출액 특례적용 관련)
Regulatory Filings Classification · 1% confidence The document is a short announcement from the Korea Exchange regarding a specific regulatory status (revenue exemption for R&D excellence) for the company Corestem. It does not contain full financial statements or a comprehensive report, but rather serves as a regulatory notification. Since it does not fit into specific categories like dividends, M&A, or share issues, it falls under the general regulatory announcement category.
2021-01-26 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details changes in share ownership by Hanwha Investment & Securities in the company Corestem. This falls under the category of Major Shareholding Notification as it tracks significant ownership thresholds.
2020-11-30 Korean
기타경영사항(자율공시)(미국 MGH가 미국 FDA에 신청한 뉴로나타-알주의 응급 임상 요청에 대한 승인)
Legal Proceedings Report Classification · 1% confidence The document is a short regulatory disclosure (자율공시) from Corestem regarding the FDA approval of an emergency clinical trial request for their product 'Neurata-R' by Massachusetts General Hospital. It does not fit into specific categories like financial reports, dividends, or M&A, and is a standard regulatory announcement of a business event, making 'RNS' the most appropriate classification.
2020-11-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.